Peer-influenced content. Sources you trust. No registration required. This is HCN.
Medical News Today (MNT)
Emerging research suggests vitamin D may influence immune tolerance and gut interactions in IBD, though findings remain exploratory and adjunctive.
Ambulatory Care Nursing April 16th 2026
Pharmacy Times
This updated indication now allows the use of upadacitinib prior to the use of tumor necrosis factor (TNF) blocking agents in patients for whom use of these treatments is clinically inadvisable and who have received at least 1 approved systemic therapy.
Clinical Pharmacology October 14th 2025